Investing Profile

Jason Camm

InvestorVC
Managing Director & Chief Medical Officer at Thiel Capital
thielcapital.comWest Hollywood, California
Photo of Jason Camm, Managing Director at Thiel Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Thiel Capital Managing Director
$100K - $1.5M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
ATAI Life Sciences
Series DMar 2021$160M
Series CNov 2020$93M
Convertible NoteApr 2020$25M
$690M
Co-investors: Peter Thiel (Founders Fund), Steve Jurvetson (Future Ventures), Stephen Hays (What If Ventures), Maryanna Saenko (Future Ventures), Matias Serebrinsky (PsyMed Ventures), Victor Douce (Brkfst Club), Ken Belotsky (Negev Capital), Miyuki Matsumoto (Aglae Ventures), Martin Alexander Gershon (Endeavor Venture Funds), Christian Angermayer (Presight Capital), Janice Bourque (Hercules Capital), Nico Wittenborn (Adjacent), Akshay Sriprasad
EnClear Therapies
Series AFeb 2020$10M
SeedMar 2019$2M
$12M
Co-investors: Peter Thiel (Founders Fund), Michael Ströck (Calm/Storm Ventures), Fabian Hansen (Presight Capital)